This Viewpoint discusses the public health effects of the US Food and Drug Administration’s (FDA) recent decision to authorize 4 flavored nicotine products.
No takes yet. Share an insight, caveat, or question.
Julie L Campbell (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: